tm logo
BIOLUMI
Live/Registered
PARTIAL SECTION 71 ACCEPTED

on 19 May 2022

Last Applicant/ Owned by

The 21st Floor, Snibe Building

Shenzhen, Guangdong

CN

Serial Number

79177788 filed on 08th Jul 2015

Registration Number

5047458 registered on 27th Sep 2016

in the Principal Register

Correspondent Address

Nazly Aileen Bayramoglu

Nazly Aileen Bayramoglu

1540 West Warm Springs Road, Suite 100

Henderson, NV 89014

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

BIOLUMI

Blood testing apparatus; massage apparatus; Testing apparatus for medical purposes, namely, medical testing instrument for testing blood samples, body fluids and body tissue samples; Apparatus for use in medical analysis, namely, medical analyzer for analysis of blood samples, body fluids and body tissue samples;Diagnostic apparatus for medical purposes, namely, medical diagnostic analyzer for ana Read More

Classification Information


Class [010]
Medical Instrument Products


Blood testing apparatus; massage apparatus; Testing apparatus for medical purposes, namely, medical testing instrument for testing blood samples, body fluids and body tissue samples; Apparatus for use in medical analysis, namely, medical analyzer for analysis of blood samples, body fluids and body tissue samples;Diagnostic apparatus for medical purposes, namely, medical diagnostic analyzer for analyzing blood samples, body fluids and body tissue samples; radiotherapy apparatus; Ultrasonic devices for medical use, namely, clinical ultrasonic diagnostic apparatus; artificial limbs; Multifunction corsets for medical purpose, namely, diagnosis and therapeutic corsets for medical purpose; suture materials

Class [005]
Pharmaceutical Products


[ Drugs for medical purposes for treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin disease; chemical preparations for the diagnosis of pregnancy; Medicated serums for invitro diagnosis of pregnancy and treatment of blood conditions during pregnancy; Serotherapeutic medicines for the treatment of hepatitis; cultures of microorganisms for medical and veterinary use; biological preparations for pharmaceutical purposes for treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; Chemical preparations for pharmaceutical purposes, namely, for diagnosis or treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; Diagnostic preparations for medical purposes, namely, for diagnosing or detecting tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; enzymes for medical purposes; enzyme preparations for medical purposes ]

Mark Details


Serial Number

No 79177788

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
18th Apr 2023PARTIAL INVALIDATION PROCESSED BY THE IB
13th Mar 2023GENERIC MADRID TRANSACTION CREATED
13th Mar 2023GENERIC MADRID TRANSACTION SENT TO IB
19th Jan 2023PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
19th May 2022REGISTERED - PARTIAL SEC 71 ACCEPTED
19th May 2022NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
10th May 2022TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
30th Apr 2022POST REGISTRATION ACTION MAILED - SEC.71
27th Apr 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
27th Sep 2021TEAS SECTION 71 RECEIVED